Advanced in Hypertension

Dr. Parminder Singh

Interventional Cardiology
A. Benchimol M.D. P.C.
1331 N 7th St Ste 375, 
Phoenix, AZ 
Offers Telehealth
Advanced in Hypertension
A. Benchimol M.D. P.C.
1331 N 7th St Ste 375, 
Phoenix, AZ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Parminder Singh is an Interventional Cardiologist in Phoenix, Arizona. Dr. Singh is rated as an Advanced provider by MediFind in the treatment of Hypertension. His top areas of expertise are Arterial Embolism, Angina, Carotid Artery Disease, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

His clinical research consists of co-authoring 55 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Interventional Cardiology
Licenses
Internal Medicine in AZ
Hospital Affiliations
Banner Estrella Medical Center
Banner Boswell Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MercyCare
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
VibrantRx
  • MEDICARE PDP
  • OTHER MEDICARE
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

A. Benchimol M.D. P.C.
1331 N 7th St Ste 375, Phoenix, AZ 85006
Call: 602-307-0070
Other Locations
Cardiac Cath. Lab of Phoenix
1910 E Thomas Rd Ste 101, Phoenix, AZ 85016
Call: 480-878-4740

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

A Pilot Study of Tazemetostat and Pembrolizumab (MK-3475) in Advanced Urothelial Carcinoma
A Pilot Study of Tazemetostat and Pembrolizumab (MK-3475) in Advanced Urothelial Carcinoma
Enrollment Status: Active_not_recruiting
Publish Date: December 17, 2025
Intervention Type: Procedure, Drug, Biological
Study Drugs: Pembrolizumab, Tazemetostat
Study Phase: Phase 1/Phase 2
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: November 20, 2025
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Atezolizumab, Cisplatin, Fluorouracil, Gemcitabine, Mitomycin C
Study Phase: Phase 3
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Other, Biological, Procedure
Study Drug: Pembrolizumab
Study Phase: Phase 3
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Enrollment Status: Completed
Publish Date: May 22, 2025
Intervention Type: Drug
Study Drug: Atezolizumab
Study Phase: Phase 2
A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide in Patients With Newly Diagnosed Metastatic Sensitive Prostate Cancer
A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide in Patients With Newly Diagnosed Metastatic Sensitive Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: March 19, 2025
Intervention Type: Drug
Study Drugs: TAK-700, Bicalutamide
Study Phase: Phase 3
A Randomized Phase 2 Trial of Cisplatin/Gemcitabine With or Without M6620 (VX-970) in Metastatic Urothelial Carcinoma
A Randomized Phase 2 Trial of Cisplatin/Gemcitabine With or Without M6620 (VX-970) in Metastatic Urothelial Carcinoma
Enrollment Status: Completed
Publish Date: March 03, 2025
Intervention Type: Drug
Study Drugs: Berzosertib, Cisplatin, Gemcitabine Hydrochloride
Study Phase: Phase 2
Dose Escalation and Expansion Clinical Study to Evaluate the Safety and Efficacy of ELU001 in Subjects Who Have Advanced, Recurrent or Refractory FRα Overexpressing Tumors
Dose Escalation and Expansion Clinical Study to Evaluate the Safety and Efficacy of ELU001 in Subjects Who Have Advanced, Recurrent or Refractory FRα Overexpressing Tumors
Enrollment Status: Terminated
Publish Date: August 07, 2024
Intervention Type: Drug
Study Drug: ELU001
Study Phase: Phase 1/Phase 2
Phase 1 Study With Expansion Cohorts to Assess the Safety, Tolerability, and Activity of Oraxol (Paclitaxel + HM30181A) in Combination With Pembrolizumab in Subjects With Advanced Solid Malignancies
Phase 1 Study With Expansion Cohorts to Assess the Safety, Tolerability, and Activity of Oraxol (Paclitaxel + HM30181A) in Combination With Pembrolizumab in Subjects With Advanced Solid Malignancies
Enrollment Status: Terminated
Publish Date: May 19, 2023
Intervention Type: Drug, Biological
Study Phase: Phase 1
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
Enrollment Status: Terminated
Publish Date: April 05, 2023
Intervention Type: Other, Drug
Study Drug: Aspirin
Study Phase: Phase 3
Phase II Study Evaluating Combination Chemotherapy + Radiotherapy (RT) With Avelumab in Muscle Invasive Bladder Cancer
Phase II Study Evaluating Combination Chemotherapy + Radiotherapy (RT) With Avelumab in Muscle Invasive Bladder Cancer
Enrollment Status: Completed
Publish Date: January 06, 2023
Intervention Type: Other, Radiation, Drug
Study Drugs: Avelumab, Cisplatin, 5-Fluorouracil, Mitomycin C
Study Phase: Phase 2
Proleukin Observational Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Proleukin Observational Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Enrollment Status: Completed
Publish Date: June 13, 2019
View 10 Less Clinical Trials

55 Total Publications

Circulating Tumor DNA in Urothelial Cancer: Practical Applications in Oncology Clinic.
Circulating Tumor DNA in Urothelial Cancer: Practical Applications in Oncology Clinic.
Journal: JCO oncology practice
Published: December 16, 2025
View All 55 Publications
Similar Doctors
Distinguished in Hypertension
Dr. Ziad Elghoul
Interventional Cardiology
Distinguished in Hypertension
Dr. Ziad Elghoul
Interventional Cardiology

Office

1960 W Frye Rd Ste 5, 
Chandler,, AZ 
 (14.4 miles away)
480-917-5900
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ziad Elghoul is an Interventional Cardiologist in Chandler,, Arizona. Dr. Elghoul is rated as a Distinguished provider by MediFind in the treatment of Hypertension. His top areas of expertise are Angina, Coronary Heart Disease, Atherosclerosis, Atrial Fibrillation, and Pacemaker Implantation.

Faran Bashir
Distinguished in Hypertension
Dr. Faran Bashir
Interventional Cardiology
Distinguished in Hypertension
Dr. Faran Bashir
Interventional Cardiology

Affiliated Cardiologists Of Arizona PC

1331 N 7th St Ste 400, 
Phoenix, AZ 
 (0.9 miles away)
602-277-6181
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Faran Bashir is an Interventional Cardiologist in Phoenix, Arizona. Dr. Bashir is rated as a Distinguished provider by MediFind in the treatment of Hypertension. His top areas of expertise are Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Fainting, and Pacemaker Implantation.

Distinguished in Hypertension
Dr. William Bailey
Interventional Cardiology
Distinguished in Hypertension
Dr. William Bailey
Interventional Cardiology

Cardiovascular Consultants

3805 E Bell Rd Ste 3100, 
Phoenix, AZ 
 (11.8 miles away)
602-867-8644
Languages Spoken:
English
See accepted insurances
Offers Telehealth

William Bailey is an Interventional Cardiologist in Phoenix, Arizona. Dr. Bailey is rated as a Distinguished provider by MediFind in the treatment of Hypertension. His top areas of expertise are Familial Hypertension, Hypertension, Glucocorticoid-Remediable Aldosteronism, and Familial Neurocardiogenic Syncope.

VIEW MORE HYPERTENSION DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Singh's expertise for a condition
ConditionClose
      • Advanced
      • Adenosine Deaminase 2 Deficiency
        Dr. Singh is
        Advanced
        . Learn about Adenosine Deaminase 2 Deficiency.
        See more Adenosine Deaminase 2 Deficiency experts
      • Angina
        Dr. Singh is
        Advanced
        . Learn about Angina.
        See more Angina experts
      • Apoplexy
        Dr. Singh is
        Advanced
        . Learn about Apoplexy.
        See more Apoplexy experts
      • Arterial Embolism
        Dr. Singh is
        Advanced
        . Learn about Arterial Embolism.
        See more Arterial Embolism experts
      • Atherosclerosis
        Dr. Singh is
        Advanced
        . Learn about Atherosclerosis.
        See more Atherosclerosis experts
      • Atrial Fibrillation
        Dr. Singh is
        Advanced
        . Learn about Atrial Fibrillation.
        See more Atrial Fibrillation experts
      View All 23 Advanced Conditions
      • Experienced
      • Acute Coronary Syndrome
        Dr. Singh is
        Experienced
        . Learn about Acute Coronary Syndrome.
        See more Acute Coronary Syndrome experts
      • Aortic Regurgitation
        Dr. Singh is
        Experienced
        . Learn about Aortic Regurgitation.
        See more Aortic Regurgitation experts
      • Aortic Valve Replacement
        Dr. Singh is
        Experienced
        . Learn about Aortic Valve Replacement.
        See more Aortic Valve Replacement experts
      • Aortic Valve Stenosis
        Dr. Singh is
        Experienced
        . Learn about Aortic Valve Stenosis.
        See more Aortic Valve Stenosis experts
      • Arrhythmias
        Dr. Singh is
        Experienced
        . Learn about Arrhythmias.
        See more Arrhythmias experts
      • Arrhythmogenic Right Ventricular Cardiomyopathy
        Dr. Singh is
        Experienced
        . Learn about Arrhythmogenic Right Ventricular Cardiomyopathy.
        See more Arrhythmogenic Right Ventricular Cardiomyopathy experts
      View All 62 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.